(Q54167974)

25 May 2018

title

Physicochemical properties, pharmacokinetics, and biodistribution of gadoteridol injection in rats and dogs. (English)

1 reference

25 May 2018

1 reference

Eakins MN

1

1 reference

25 May 2018

Eaton SM

2

1 reference

25 May 2018

Fisco RA

3

1 reference

25 May 2018

Hunt RJ

4

1 reference

25 May 2018

Ita CE

5

1 reference

25 May 2018

Katona T

6

1 reference

25 May 2018

Owies LM

7

1 reference

25 May 2018

Schramm E

8

1 reference

25 May 2018

Sulner JW

9

1 reference

25 May 2018

Thompson CW

10

1 reference

25 May 2018

publication date

1 July 1995

1 reference

25 May 2018

published in

Academic Radiology

1 reference

25 May 2018

volume

2

1 reference

25 May 2018

issue

7

1 reference

25 May 2018

page(s)

584-591

1 reference

25 May 2018

Dissociation of gadolinium chelates in mice: relationship to chemical characteristics

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

A specific radioimmunoassay for the measurement of gadoteridol, a contrast agent for magnetic resonance imaging in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

The routine fitting of kinetic data to models: a mathematical formalism for digital computers

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

Statistical estimations in pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

1 reference

7 January 2021

Ionic versus nonionic MR imaging contrast media: operational definitions

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

Pharmacokinetic analysis of blood distribution of intravenously administered 153Gd-labeled Gd(DTPA)2- and 99mTc(DTPA) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement Agent

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

Excretion of gadopentetate dimeglumine in human breast milk.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

The relationship between thermodynamics and the toxicity of gadolinium complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

Reaction of gadolinium chelates with endogenously available ions

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980120-5

7 January 2021

10.1016/S1076-6332(05)80120-5

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018